Respiratory Infections

Following a deadly pneumonia outbreak in a Chinese hospital last year, researchers have identified a dangerous new superbug that is drug-resistant and highly virulent.

Alan Gross, PharmD, shares the drawbacks of some of the current prediction tools used for pneumonia.

WHO report confirms that “the world is running out of antibiotics” to treat resistant priority pathogens

Lefamulin, a pleuromutilin antibiotic, continues to meet primary endpoints for the treatment of community acquired bacterial pneumonia (CABP) in clinical trials.

Alex Rinehart, PhD, explains if cabotegravir interacts with any other medications.

Researchers from Imperial College in London have created a scoring system designed to predict 10-year tuberculosis (TB) risk in adult contacts of index cases.

As practitioners continue to mistake the worsening of asthma symptoms for bacterial respiratory infections, more antibiotics are being prescribed, many times, inappropriately.

Alan Gross, PharmD, shares how an early diagnosis of multidrug-resistant pneumonia can work towards improving patient outcomes.

The CDC has launched an educational initiative called “Get Ahead of Sepsis,” which underscores the early recognition and timely treatment of sepsis.

In a recent article, researchers discuss common fungal respiratory diseases in non-immunocompromised patients.

The CDC shares ACIP’s recommendations regarding the prevention and control of seasonal influenza with vaccines for the 2017-2018 season.

The results of a new study from the United Kingdom reveal that oral prednisone had no effect on the severity and duration of symptoms in adult patients suffering from bronchitis.

Jason Pogue, PharmD, BCPS-ID, explains the clinical significance of his research team’s findings regarding the use of ceftolozane-tazobactam to treat Pseudomonas infections.

A recent study investigates what causes relapse in those with multiple sclerosis and sought to glean insight into the brain activity of patients with MS during respiratory infections.

Negative pressure isolation rooms will be in high-demand during an outbreak of SARS, MERS, or pandemic flu, but how will we meet these needs?

Lucy B. Palmer, MD, from Stony Brook University School of Medicine in New York argues that inhaled antibiotic therapy provides higher drug concentrations of antibiotics with fewer systemic side effects than IV therapy.

Researchers find that performing a TB diagnostic test in a clinic as opposed to a centralized laboratory greatly reduced patients’ time to treatment.

Researchers from the University of Mississippi report a case of an HIV-positive man with pneumonia due to MRSA who was treated with dalbavancin.

The results of a new study reveal increased risk of cardiovascular disease in adults previously hospitalized for pneumonia or sepsis.

New research on Zika, cases of swine flu infections, parallels between Zika and HIV, a new warning sign of HIV infection, and an increase in cyclospora cayetanensis infections in United States make up the top 5 articles this week.

Jason Pogue, PharmD, BCPS-ID, explains how ceftolozane-tazobactam differs from other beta-lactams for treating Pseudomonas infections.

Researchers believe they have developed an effective genetic roadmap to assist in the identification and characterization of infections in the lower respiratory tract.

The Clinton County health commissioner, Pamela Walker Bauer, MPH, RS has confirmed 11 cases of H3N2v flu linked with an Ohio fair.

In a new study published in the journal Vaccine, researchers examine the antibody response to the flu vaccine in pregnant women and their babies.

The latest World Health Organization report points to high MERS transmission risk in hospitals.

After Italy’s parliamentary decision to mandate vaccines, France health officials follow suit, requiring parents to vaccinate their children against 11 common illnesses starting in 2018.

As the IAS Conference on HIV Science wraps up this week, this Public Health Watch report takes a closer look at the challenges that remain when it comes to treating HIV.

A recent WHO news release reports that infant immunization rates continue to fall short of the global immunization target of 90%.

Jason Pogue, PharmD, BCPS-ID, explains his team’s study regarding the susceptibility of Pseudomonas isolates to ceftolozane/tazobactam.

Doctor Without Borders is criticizing countries and government agencies alike for seemingly downplaying the impact of tuberculosis around the world.